Cardiology Considerations in Immuno-Oncology Therapy

Please join us for our next Pharmacy Resident Seminar presentation on Tuesday, October 11, 2022, presented by UIC College of Pharmacy PGY1 Pharmacy Resident, Kristyn Krajewski, PharmD.

Type of Activity: Knowledge-based                                    Target Audience: Pharmacists

Time: Tuesday, October 11, 2022,  12:30 pm - 1:20 pm

Fees: There is no charge for attending this activity

Location: Chicago, Room 134-1 and via Zoom

Zoom Meeting Information:
Meeting link: https://go.uic.edu/residentseminar2022-2023
Meeting number: 871 4292 0130
Password: 3Rx8KyKR
Or
Join by phone: 1-312-626-6799 (Chicago)
Meeting ID: 871 4292 0130
Passcode: 25699265

Learning Objectives :

At the completion of this activity, the participant will be able to:

• Describe the mechanism of action of immune checkpoint inhibitors (ICIs) and Chimeric Antigen Receptor (CAR)-T therapy in the cancer treatment
• Explain the cardiac safety concerns and monitoring parameters associated with immuno-oncology therapy
• Summarize current evidence for treatment of cardiac toxicity due to immuno-oncology therapy

Disclosure:  The speaker, planning committee members, and reviewers who contributed to this activity have no relevant conflicts of interest to disclose. Mentor, Dr. Latha Radhakrishnan, is on the Speaker’s Bureau for Astra Zeneca, Bristol Myers Squibb, Exelixis, and Taiho Oncology. All relevant financial relationships listed for Dr. Radhakrishnan have been mitigated.